Alcon Investigative Site
Johns Creek, Georgia, 30097, United States
NCT Number: NCT03034928
The primary objective is to evaluate corneal staining observed after 2 hours of wear with contact lenses with investigational coating against PureVision™ lenses, all pre-cycled with OPTI-FREE® RepleniSH® multi-purpose disinfection solution.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Johns Creek, Georgia, 30097, United States
In this contralateral crossover study, qualifying subjects will wear a total of 2 pairs of study contact lenses. Lenses will be worn according to a randomized lens sequence assignment. Each pair will consist of a test lens (Test 1 or Test 2) and a control lens.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Contact lens with investigational coating 1 pre-cycled in OPTI-FREE® RepleniSH® Multi-Purpose Disinfecting Solution (MPDS)
Other names: Test 1
Balafilcon A contact lens pre-cycled OPTI-FREE® RepleniSH® MPDS
Other names: Bausch & Lomb PureVision™, Control 1, Control 2
Multipurpose contact lens solution
Contact lens with investigational coating 2 pre-cycled in OPTI-FREE® RepleniSH® MPDS
Other names: Test 2
Time frame: Day 1 after 2 hours of wear, each product
Percent of solution-related corneal staining area was assessed first in each of the 5 corneal regions: central, superior, nasal, inferior, and temporal. The average of corneal staining area was then calculated as the average over all 5 regions. A higher percentage reflects more damage to the corneal surface. Both eyes contributed to the analysis. No hypotheses were formulated; no inferences were made and only descriptive statistics were used in the reporting.
Alcon Research
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06668246
Ametropia, Eye Diseases
Brest, France
View Trial DetailsNCT05010512
Ametropia, Eye Diseases
Orlando, Florida, United States
View Trial DetailsNCT04908488
Ametropia, Astigmatism
Los Angeles, California, United States
View Trial DetailsNCT04532099
Ametropia, Eye Diseases
Longwood, Florida, United States
View Trial Details